Evidence map›Paper›PMID 28443027›Full record

ArticleFrontiers in physiology2017

Personalized Medication Response Prediction for Attention-Deficit Hyperactivity Disorder: Learning in the Model Space vs. Learning in the Data Space.

Hin K Wong, Paul A Tiffin, Michael J Chappell, Thomas E Nichols, Patrick R Welsh, Orla M Doyle, Boryana C Lopez-Kolkovska, Sarah K Inglis, David Coghill, Yuan Shen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Toward Precision Medicine in ADHD.Frontiers in behavioral neuroscience · 2022
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Hin K WongWarwick Manufacturing Group, Institute of Digital Healthcare, University of WarwickCoventry, UK.
Paul A TiffinMental Health and Addiction Research Group, Department of Health Sciences, University of YorkYork, UK.
Michael J ChappellSchool of Engineering, University of WarwickCoventry, UK.
Thomas E NicholsWarwick Manufacturing Group, Institute of Digital Healthcare, University of WarwickCoventry, UK.
Patrick R WelshSchool of Psychology, Newcastle UniversityNewcastle upon Tyne, UK.
Orla M DoyleCentre for Neuroimaging Sciences, King's College LondonLondon, UK.
Boryana C Lopez-KolkovskaWarwick Manufacturing Group, Institute of Digital Healthcare, University of WarwickCoventry, UK.
Sarah K InglisDivision of Maternal and Child Health Sciences, Ninewells Hospital and Medical School, University of DundeeDundee, UK.
David CoghillDepartments of Paediatrics and Psychiatry, University of MelbourneMelbourne, VIC, Australia.
Yuan ShenSchool of Computer Science, University of BirminghamBirmingham, UK.
Peter TiñoSchool of Computer Science, University of BirminghamBirmingham, UK.
University of Warwick · GBUniversity of Birmingham · GBKing's College London · GBNewcastle University · GBNinewells Hospital · GBUniversity of Melbourne · AUUniversity of York · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attention-Deficit Hyperactive Disorder (ADHD) is one of the most common mental health disorders amongst school-aged children with an estimated prevalence of 5% in the global population (American Psychiatric Association, 2013). Stimulants, particularly methylphenidate (MPH), are the first-line option in the treatment of ADHD (Reeves and Schweitzer, 2004; Dopheide and Pliszka, 2009) and are prescribed to an increasing number of children and adolescents in the US and the UK every year (Safer et al., 1996; McCarthy et al., 2009), though recent studies suggest that this is tailing off, e.g., Holden et al. (2013). Around 70% of children demonstrate a clinically significant treatment response to stimulant medication (Spencer et al., 1996; Schachter et al., 2001; Swanson et al., 2001; Barbaresi et al., 2006). However, it is unclear which patient characteristics may moderate treatment effectiveness. As such, most existing research has focused on investigating univariate or multivariate correlations between a set of patient characteristics and the treatment outcome, with respect to dosage of one or several types of medication. The results of such studies are often contradictory and inconclusive due to a combination of small sample sizes, low-quality data, or a lack of available information on covariates. In this paper, feature extraction techniques such as latent trait analysis were applied to reduce the dimension of on a large dataset of patient characteristics, including the responses to symptom-based questionnaires, developmental health factors, demographic variables such as age and gender, and socioeconomic factors such as parental income. We introduce a Bayesian modeling approach in a "learning in the model space" framework that combines existing knowledge in the literature on factors that may potentially affect treatment response, with constraints imposed by a treatment response model. The model is personalized such that the variability among subjects is accounted for by a set of subject-specific parameters. For remission classification, this approach compares favorably with conventional methods such as support vector machines and mixed effect models on a range of performance measures. For instance, the proposed approach achieved an area under receiver operator characteristic curve of 82-84%, compared to 75-77% obtained from conventional regression or machine learning ("learning in the data space") methods.

Indexed as

attention-deficit hyperactivity disorderBayesian inferencemachine learningmethylphenidatemixed effects modelpersonalized medicineprognosistreatment response

Identifiers

PMID28443027
PMCPMC5387107
OpenAlexW2606925367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.